Day 4: Final scientific sessions and Krotoski closing lecture.
Day 4: Final scientific sessions and Krotoski closing lecture.
Day 1: Pre-meeting courses and Opening ceremony
Day 3: Tuesday 13th June
It is common belief and a dogma of the Western school medicine that valid results with the extracts of natural products can only be obtained if individual constituents are isolated and purified to the highest grade. This entails that most, if not all, scientific papers describing research in this field are based on monotherapies with ultrapure products.
The course is free and is composed of 8 modules.
Statement on the Election of Dr. Tedros Adhanom Ghebreyesus as the New Director-General of the World Health Organization
Professor Austin Burt has been awarded a President's Medal for his work engaging the public in malaria-control projects across sub-Saharan Africa.
The accolade is given out as part of the College’s annual President's Awards for Excellence in Societal Engagement. These awards celebrate staff, students and community partners who have gone the extra mile to bring the College’s work to the wider public. Awardees judged to have made particularly exceptional contributions are selected to receive the President’s Medal for Excellence in Societal Engagement.
|"Now, more than ever, universities should be in and of the world. We cannot afford to retreat to ivory towers"
– Professor Maggie Dallman, Associate Provost (Academic Partnerships)
The Societal Engagement awards form part of the President’s Awards for Excellence programme, with similar prizes also being given for research and education.
The Nigeria Prize for Science: Innovations in Malaria Control
The theme for the 2017 Nigeria Prize for Science is Innovations in Malaria Control. This competition is organized by Nigeria LNG Limited and is in line with its vision of helping to build a better Nigeria. Read the announcement here.
Antimalarial candidate holds promise as a single dose
A new antimalarial candidate could pave the way for a single-dose treatment that boots malaria eradication when used in combination with other preventative measures. Read the SciDev.Net article "Antimalarial candidate holds promise as a single dose" here and the article "Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase" here.
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at email@example.com
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
[CAPE TOWN] A new antimalarial candidate could pave the way for a single-dose treatment that boots malaria eradication when used in combination with other preventative measures.
This is a translation of the Worcester Polytechnic Institute press release
Worcester, Mass. – April 24, 2017 – Quand les remèdes prescrits n’arrivaient plus à guérir 18 impaludés en situation désespérée, leur médecin traitant dans une clinique du Congo, en se basant sur les procedures du “compassionate use” de l’EMA, a eu recours à un mécicament non encore officiellement autorisé et consistant en comprimés de feuilles séchées de la plante Artemisia annua (désignés sous DLA).
In February 2017, malaria experts from around the world gathered in Kampala, Uganda to attend "Malaria: From Innovation to Eradication", a conference organized by Keystone Symposia in collaboration with MESA. Eight scientists shared their cutting edge research with MESA, on film.
“As a researcher working in a country that has decided to take on the challenge of eliminating malaria, the knowledge in the paper is enriching”. This is how Sandra Chishimba chose her ‘Top Pick’ article for World Malaria Day 2017. MESA (Malaria Eradication Scientific Alliance) asked five experts what recent paper has helped them in their effort to outsmart malaria. The papers had to be open access, authored by another group, and published in the last 12 months.
24 APRIL 2017 | GENEVA, NAIROBI - At an event on the eve of World Malaria Day in Nairobi, WHO called today for accelerated scale-up of efforts to prevent malaria and save lives.
In sub-Saharan Africa, which shoulders 90% of the global malaria burden, more than 663 million cases have been averted since 2001. Insecticide-treated nets have had the greatest impact, accounting for an estimated 69% of cases prevented through control tools.
World Malaria Day 2017 Statement from Dr. Kesetebirhan Admasu Chief Executive Officer, Roll Back Malaria Partnership
We can be the generation to end malaria for good
April 25, 2017 – (Geneva, Switzerland)
Bigpharma-WHO-Gates desperately try to ignore peer reviewed scientific papers documenting the spread of ACT resistance in at least 12 African countries (see “Artemisinin resistance In Africa” www.malariaworld.org).
Several medical teams in Africa have demonstrated in randomized, double blind clinical trials that Artemisia infusions are powerful in therapy and prophylaxis (see “Breaking news from clinical trials with Artemisia plants” www.malariaworld.org).
The Eltahir group at MIT has recently published a pioneering study which makes it possible to plan resettlement and new villages in ways which will permanently minimize malaria transmission, because of ecological design. This is especially valuable for engineers planning resettlement communities related to large reservoirs and irrigation systems.
Such safe designs reduce the need for the ephemeral methods based on drugs, bednets and insecticides.
The report is:
A thesis from Sudan presents troubling facts
Hassan Humeida. Der Verlauf von Malaria bei Patienten mit Diabetes mellitus in Afrika - Feldforschungen im Zentral-Sudan - Dissertation. Giessen, Februar 2011 Justus-Liebig-Universität
In Mexico eight species of Artemisia have been described and among them just Artemisia ludoviciana has been empirically used in the treatment of intermittent fever (malaria). To know whether this Mexican Artemisia had antimalarial activity several in vivo experiments were performed, on mice infected by Plasmodium yoelii yoelii, in a four-day test scheme. The results of the in vivo experiments showed that the parasite reproduction was inhibited up to 98.6% at the fifth day.
28 February 2017, WHO
Members of the WHO Strategic Advisory Group (SAG) on malaria eradication recently convened in Geneva to review and define a set of work streams for the next 2-year period. The proposed scope of work is cross-cutting and spans a breadth of domains: biological, technical, financial, socio-economic, political and environmental.
27 February 2017
This blog was the result of my preparing for the recent RBM meeting in Geneva. I hope it will be useful for any of you on National Malaria Contol Programs. It is about the need for:
Formation of National Inter-Ministerial Boards for Malaria Control
Keystone Symposia malaria meeting in Kampala - Day 1
Sunday, 19 February 2017
Keystone Symposia malaria meeting in Kampala - Day 2
Monday, 20 February 2017
Keystone Symposia malaria meeting in Kampala - Day 3
Tuesday, 21 February 2017
Today’s morning session focused on tailoring packages of interventions to achieve the greatest impact in a specific setting.
Keystone Symposia malaria meeting in Kampala - Day 4
Wednesday, 22 February 2017
Today’s sessions focused on tools for malaria elimination, including promising vaccine and drug candidates, and novel vector control.
This morning was full of exciting science on the malaria parasite and its interaction with human and mosquito hosts. A common message from the presenters was the dynamic nature of parasite populations. Today’s parasites are adapting to evolutionary pressure and will not be the same in the future. As countries reach elimination, tools and strategies need to adapt as well.
received from Emile Schmitz, Athus
Caused not by racial or religious conflict, but by greed.
Every year WHO claims that the battle against malaria is won and that the number of malaria infections has been halved. Unfortunately, in several countries the disease is exploding. In Burundi the number of infections has increased from 4 716 152 in 2014 to 7 813 958 in 2016.
A recent mission of WHO to this country had to confess a complete failure of LLINs and ACTs.
4 years ago, a heated debate concerning malaria prophylaxis had been triggered on www.malariaworld.org. It concerned the very promising results obtained by Dr Patrick Ogwang, with an herbal product called Artavol, he had developed with the Ministry of Health in Uganda. Peer reviewed papers and press releases are easily found on internet.
Since the Trump administration came into office, there are real uncertainties about the long-standing US Presidential Malaria Initiaitive (the PMI), which I helped start in 2005. Firstly, the Administrator Tim Ziemer, who has given the Initiative real stability for 8 years, has resigned. Secondly it appears that the very conservative Newt Gingrich will take over USAID which funds the PMI within the US State Department. Gingrich is opposed to USAID and might dismantle it. Fortunately the new US Secty of State Rex Tillerson has gone on record as favoring the health programs of USAID.